Cystic Dilation of Bile Duct: New Clinical Classification and Treatment Strategy
董家鸿,郑秀海,夏红天,赵向前,梁斌,杨滔,曾建平,黄志强
DOI: https://doi.org/10.3760/cma.j.issn.1673-9752.2013.05.012
2013-01-01
Abstract:Objective To suggest a new clinical classification of the cystic dilatation of bile duct (CDBD),and to design the treatment modality according to different classifications.Methods The clinical data of 434 patients with CDBD who were admitted to the Chinese PLA General Hospital from June 1993 to June 2010 were retrospectively analyzed.The data of computed tomography (CT) and magnetic resonance cholangiopancreatography (MRCP) were collected.A new clinical classification of CDBD was proposed based on the site,pathological features,pathogenic factors of CDBD and relevant surgical procedures.The clinical condition,surgical procedure,treatment efficacy and results of follow-up of CDBD patients based on the new classification were analyzed,and then proper surgical treatment method for patients with different types of CDBD was suggested.The data were analyzed using the chi-square test,and Fisher exact probability was applied when the theoretical frequency ＜ 5 or the observed frequency ＜ 30.Results CDBD was classified into 5 types according to the pathological features and the location of cystic dilation in the biliary tree:(1) Type A:cystic dilatation of the peripheral biliary tree was limited to the intrahepatic bile ducts.This type could be s1ubdivided into type A1 (cystic dilation of the bile duct was limited to one hepatic lobe or several segments) and type A2 (cystic dilation of the bile duct was diffused to entire intrahepatic biliary tree).(2) Type B:cystic dilation of central large intrahepatic bile duct above the hilar convergence.Commonly the disease presented a single localized form limited to one hepatic lobe (type B1),and cystic dilation in hilar convergence or in bilobar central bile ducts (type B2) was rare.(3) Type C:cystic dilation of the extrahepatic bile duct.According to whether the intrapancreatic bile duct was involved,this type could be divided into type C1 (without intrapancreatic bile duct involvement) and C2 (with intrapancreatic bile duct involvement).(4) Type D:cystic dilation involving both the intra-and extrahepatic bile ducts.According to the range of involvement,this type could be divided into type D1 (cystic dilation limited to one lobe) and D2 (cystic dilation expanded to bilobar bile ducts).(5) Type E:Cystic dilation of the distal common bile duct.Of the 434patients,there were 24 patients with type A CDBD (type A1:17 patients,type A2:7 patients),13 patients with type B (type B1:10 patients,type B2:3 patients),300 patients with type C (type C1:56 patients,type C2:244 patients),96 patients with type D (type D1:17 patients,type D2:79 patients),and 1 patient with type E.In 24 patients with type A CDBD,14 were found with congenital hepatic fibrosis and 16 with polycystic kidney disease.Of the 24 patients with type A CDBD,17 patients with type A1 received partial hepatectomy,3 patients with type A2 received liver transplantation,1 patient with type A2 received puncture and drainage of cystic lesions,and 3 patients with type A2 received non-surgical treatment.Thirteen patients were with type B CDBD,12 received hepatectomy and 1 with cholangiocarcinoma received non-surgical treatment.Of the 300 patients with type C CDBD,286 received cystectomy and Roux-en-Y cholangiojejunostomy,and 14 received radical resection of cholangiocarcinoma.Of the 96 patients with type D CDBD,35 received extrahepatic cystectomy + lobectomy +Roux-en-Y cholangiojejunostomy,59 received extrahepatic cystectomy without hepatectomy,1 with type D1 and 1with type D2 received radical resection of cholangiocarcinoma.One patient with type E CDBD received endoscopic papillectomy.A total of 399 patients followed up for 1-15 years,and the mean follow-up time was 57 months.Thirty-three patients were complicated with anastomotic stricture and (or) biliary stone.There were 24 patients complicated with cholangiocarcinoma,and 15 of whom died during the follow-up.Forty-six patients received re-operation (re-anastomosis of bile duct and jejunum,choledochoscopic stone removal,radical resection of cholangiocarcinoma,and et al) because of recurrent cholangitis,anastomotic stricture,biliary stone or tumor.Other patients were free of biliary symptoms or with accidental mild cholangitis and received symptomatic treatment.The rates of symptom remission,structure and (or) biliary stone and reoperation were 88.2％ (30/34),8.8％ (3/34) and 11.8％ (4/34) in patients who received extrahepatic cystectomy + hepatectomy,and 64.4％ (38/59),28.8％ (17/59) and 35.6％ (21/59) in patients who received extrahepatic cystectomy,and with significant difference (P ＜ 0.05).Conclusion The new clinical classification of CDBD based on the location of cystic dilation in the biliary tree and its pathological features could help to make a suitable surgical plan for clinical treatment.